POTENZA, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.942
AS - Asia 11.647
EU - Europa 10.725
SA - Sud America 1.577
AF - Africa 275
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 28
Totale 51.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.455
SG - Singapore 3.391
GB - Regno Unito 2.915
CN - Cina 2.822
IT - Italia 2.514
HK - Hong Kong 1.823
VN - Vietnam 1.298
BR - Brasile 1.178
SE - Svezia 1.168
DE - Germania 940
FI - Finlandia 798
RU - Federazione Russa 566
BD - Bangladesh 535
FR - Francia 463
UA - Ucraina 395
KR - Corea 301
TR - Turchia 290
IN - India 272
CA - Canada 262
ID - Indonesia 228
BG - Bulgaria 168
NL - Olanda 138
AR - Argentina 114
MX - Messico 105
IQ - Iraq 97
JP - Giappone 88
ES - Italia 81
BE - Belgio 71
PL - Polonia 71
ZA - Sudafrica 71
IE - Irlanda 68
CZ - Repubblica Ceca 67
EC - Ecuador 66
PK - Pakistan 63
AE - Emirati Arabi Uniti 61
AT - Austria 61
CO - Colombia 59
PH - Filippine 45
CL - Cile 44
LT - Lituania 44
MA - Marocco 43
KE - Kenya 41
VE - Venezuela 40
MY - Malesia 35
UZ - Uzbekistan 34
SA - Arabia Saudita 30
PY - Paraguay 29
JO - Giordania 28
AU - Australia 27
IR - Iran 27
DZ - Algeria 26
AZ - Azerbaigian 23
BZ - Belize 22
CH - Svizzera 22
EG - Egitto 22
RO - Romania 22
CR - Costa Rica 19
JM - Giamaica 19
EU - Europa 18
PT - Portogallo 17
TN - Tunisia 17
UY - Uruguay 17
AL - Albania 16
DK - Danimarca 16
SK - Slovacchia (Repubblica Slovacca) 16
IL - Israele 15
TW - Taiwan 15
BO - Bolivia 14
NP - Nepal 14
PE - Perù 13
SI - Slovenia 13
OM - Oman 12
RS - Serbia 12
TH - Thailandia 12
DO - Repubblica Dominicana 10
GR - Grecia 10
PS - Palestinian Territory 10
BH - Bahrain 9
MK - Macedonia 9
NI - Nicaragua 9
BY - Bielorussia 8
KG - Kirghizistan 8
KZ - Kazakistan 8
NG - Nigeria 8
BN - Brunei Darussalam 7
CY - Cipro 7
LB - Libano 7
NO - Norvegia 7
QA - Qatar 7
XK - ???statistics.table.value.countryCode.XK??? 7
EE - Estonia 6
ET - Etiopia 6
GT - Guatemala 6
MD - Moldavia 6
PA - Panama 6
PR - Porto Rico 6
SN - Senegal 6
AM - Armenia 5
AO - Angola 5
HN - Honduras 5
Totale 51.130
Salva come PNG Salva come JPEG
Città #
Ashburn 2.892
Fairfield 2.631
Santa Clara 2.284
Singapore 2.086
Southend 1.888
Hong Kong 1.805
Woodbridge 1.516
Chandler 1.329
Houston 1.279
San Jose 1.054
Seattle 1.037
Ann Arbor 891
Wilmington 858
Cambridge 833
Hefei 791
Nyköping 664
Jacksonville 661
Helsinki 606
Dearborn 591
Beijing 533
London 532
Los Angeles 472
Chicago 471
New York 459
Council Bluffs 432
Modena 432
Ho Chi Minh City 417
Hanoi 296
Seoul 276
Milan 267
The Dalles 265
San Diego 248
Munich 196
Buffalo 184
Salt Lake City 179
Princeton 177
Jakarta 174
Bologna 173
Lauterbourg 164
Sofia 164
Dallas 143
Eugene 135
Izmir 135
Moscow 135
Fremont 124
Shanghai 121
Bremen 102
Orem 96
Rome 95
São Paulo 95
Boardman 87
Frankfurt am Main 79
Tampa 78
Da Nang 72
Toronto 70
Elk Grove Village 69
Phoenix 67
Columbus 66
Redwood City 66
Atlanta 62
Des Moines 62
Tokyo 61
Dublin 60
Brussels 55
Montreal 55
Nuremberg 55
Warsaw 54
Brooklyn 53
Reggio Emilia 53
Turku 53
Chennai 51
Denver 50
Haiphong 50
Miami 50
Guangzhou 40
Boston 39
Las Vegas 39
Nairobi 39
Amsterdam 38
Dong Ket 38
Mexico City 38
Parma 38
Stockholm 38
Philadelphia 37
Vienna 36
Baghdad 35
Sterling 35
Johannesburg 34
Kent 34
Ottawa 34
Lancaster 33
Redondo Beach 33
San Francisco 32
Manchester 31
Rio de Janeiro 31
Paris 30
Tashkent 30
Brno 29
Naples 29
Kilburn 28
Totale 35.764
Salva come PNG Salva come JPEG
Nome #
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 474
HHV-6A in syncytial giant-cell hepatitis 471
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 444
Kaposi's sarcoma after liver transplantation 443
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 432
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 423
B cells and herpesviruses: a model of lymphoproliferation 416
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 407
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 403
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 390
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 385
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 384
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 371
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 371
Mucorales-specific T cells in patients with hematologic malignancies 367
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 367
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 363
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 361
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 360
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 358
Acute appendicitis in adult neutropenic patients with hematologic malignancies 357
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 356
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 356
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 355
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 354
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 353
Early versus delayed palliative/supportive care in advanced cancer: An observational study 352
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 349
Translational challenges of human herpesvirus 6 chromosomal integration. 346
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 346
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 345
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 342
Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma 339
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 338
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 331
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 331
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 326
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 326
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 325
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 323
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 322
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 321
Rhodotorula infection in haematological patient: risk factors and outcome 321
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 320
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 320
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 320
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 317
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 317
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 314
Parvoviruses in blood donors and transplant patients, Italy 314
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 314
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 308
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 307
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 306
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 305
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 303
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 303
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 301
Diagnosis of aspergillosis: Role of proteomics 300
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 298
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 297
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 297
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 294
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 293
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 292
Breast Location for De Novo Extramedullary Myeloid Sarcoma 290
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals 288
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 286
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 286
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 284
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 284
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 284
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 284
'Gloves and socks' papular purpuric syndrome following primary infection with parvovirus B19: a link between dermatologists and haematologists 283
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 283
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 281
Pain and emotional distress in leukemia patients at diagnosis. 280
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 280
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 279
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 277
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 277
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 275
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 274
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 273
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 271
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 270
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 269
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 266
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 265
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response 265
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 265
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 264
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 263
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 263
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 261
How I treat HHV8/KSHV-related diseases in posttransplant patients. 258
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 256
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 254
Immunity to polyomavirus BK infection: Immune monitoring to regulate the balance between risk of BKV nephropathy and induction of alloimmunity 253
Totale 32.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.299
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.733 247 433 370 185 85 173 203 181 349 315 622 570
2022/20234.019 510 454 278 366 545 502 105 429 429 74 167 160
2023/20242.910 102 141 189 267 527 275 313 437 59 90 185 325
2024/20258.829 294 120 157 574 1.524 1.252 628 483 1.254 482 908 1.153
2025/202616.999 1.231 634 1.263 1.851 2.680 1.171 2.188 789 1.634 1.459 1.237 862
2026/2027439 439 0 0 0 0 0 0 0 0 0 0 0
Totale 51.701